A Phase I, Open-Label, Single-Dose Trial To Determine The Safety And Pharmacokinetics Of Minocin (Minocycline) For Injection In Subjects With Renal Insufficiency

Trial Profile

A Phase I, Open-Label, Single-Dose Trial To Determine The Safety And Pharmacokinetics Of Minocin (Minocycline) For Injection In Subjects With Renal Insufficiency

Discontinued
Phase of Trial: Phase I

Latest Information Update: 13 Jul 2018

At a glance

  • Drugs Minocycline (Primary)
  • Indications Renal failure
  • Focus Adverse reactions
  • Sponsors Melinta Therapeutics
  • Most Recent Events

    • 03 Jul 2018 Status changed from recruiting to discontinued.
    • 05 Mar 2018 Planned End Date changed from 1 Dec 2017 to 1 Dec 2018.
    • 05 Mar 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Dec 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top